<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 143 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page142.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=143">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 143 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 143</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=143"><img src="../thumb/143.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>112 / 2020-04                                                        Cardio-Vascular Agents - 7.3.8
   amifostine, reduc. eff.with corticoster./tetracosactide, incr. orthos-  Drug interactions: Other antihypertens.potent. antihypertens.eff.,   salts, ciclospor.may incr. creatinine lev., anticoags.eff.decr., nondepo-
   tat. hypotens. risk/incr.antihypertens.eff. with alpha blocks./TCA’s/  indomethacin dimin.act., concom. NSAID’s may furth.deteriorat.ren.  laris. neuromusc. block.agent block.enhanc.by induc. hypokalaem.
   antipsychot./anaesthet.      funct., Li-elim. reduc.,      TRI-PLEN, Sanofi-Aventis [P/S]
   REPREX, Aurobindo [P/S]      SPEC PERINDOPRIL, Specpharm [P/S]  Ramipril 2,5 mg, felodipine 2,5 mg
   Perindopril tert-butylamine  Perindopril tertbutylamine    Indications: Mild to mod.hypertens.where indiv.compon.at same
   Indications: Mild to mod.hypertens., CHF not adeq. control.with   Indications: Mild to mod.hypertens., CHF not adeq. control.with   dos.have normal.BP
   diuret.& digital.& where vasodilat. indicat  diuret.& digital.& where vasodilat. indicat  (S3) TABS, [P/S] 31/7.1/0677.
   (S3) TABS, 43/7.1.3/1033, 1034  (S3) TABS, 41/7.1.3/0652, 0653  862207-002: 30, R293,88
   716505-001: 4 mg, 30, R50,37  712615-001: 4 mg, 30, R82,44  (S3) FORTE TABS, [P/S] 31/7.1/0678.
   716506-001: 8 mg, 30, R100,70  712616-001: 8 mg, 30, R130,57  Ramipril 5 mg, felodipine 5 mg
   Dosage: Mild to mod.hypertens: 4 mg dly.bef. breakf. may be   Dosage: Mild to mod.hypertens: 4 mg once dly., may be incr.to   862215-005: 30, R464,59
   incr.to 8 mg as sngl. dos.aft.1 mnth. of treatm. Discont.concom.  8 mg once dly.aft.1 mnth. of treatm. if necess.  Dosage: Adults: 1 tab or 1 forte tab.once dly.
   diuret.bef. init.ther.       CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once dly.  Contraindications: Angioneurot.oed., ren.art. stenos., pregn.,
   CHF: Init. 2 mg as sngl.dos.in morn., may be incr.to 4 mg once   as maint.dos.  lactat., unstab.haemodynam. condits., AV block I & II, sev.hepat./
   BP accept.                   Contraindications: Angioed.hist.assoc.with prev. ACE-inhibit.ther./  ren.impairm, childr.
   Contraindications: Angioed.hist.relat.to prev. ACE inhib./ARB ther.,   angiotens.recept.block.ther., heredit./ idiopath.angioed., aort.stenos.,   Side effects: Angioneurot.oed., symptomat. hypotens., neutropen.&
   heredit./idiopath.oed., hyperthroph.obstruct. cardiomyopathy, sev.ren.   hypertroph.obstruct.cardiomyopathy, sev.ren. funct.impairm., bil./sngl.  agranulocytos., GI disturbs., dizzin., headache, dry cough, ren.funct.
                                            +
   funct.impairm. (creat.clear.&lt;30 ml/min.), anur., bil.ren.artery stenos.,   ren.artery stenos., concom. K  spar.diuret.ther., porphyr., Addison’s dis.,   impairm., hyperkalaem., hypersens.reacts., flush., fatig., periph.oed.,
   ren.art.stenos.in pts.with sngl.kidn., aort.stenos., porphyr., concom.  sulphonam.-deriv.med.hypersens., concom.Li, pregn., lactat., safety   incr.micturit.freq., lethargy, eye pain, depress., init.paradox.incr.in is-
   thiaz. diurets.in Addison’s dis., other sulphonam.-deriv. meds. hy-  & effic.in childr.not est.  chaem.chest pain, cerebr/myocard.ischaem/trans.blindn.with excess.
   persens., Li-ther., safety in childr.not est., pregn.& lactat., lact.intol.  Side effects: Hypersens.reacts.incl.angioed.of face /extremit./lips/  BP fall, gingiv.hyperplas.
   Side effects: Hypotens., hypersens.reacts.incl. angioed.of face/   tong./glottis & larynx., bld. dyscras., orthostat.effs., hypotens., MI/   Special precautions: Avoid extracorpor.treatm. lead. to bld.contact
   extremit./lips/tong./glott./larynx, syndr. start.with cholest.jaund.  CVA/ palpitat.& tachycard., CNS effs., hyperkalaem., hyponatraem.,   with negat.charg.surf.as anaphylact. reacts.poss., discont.immed.if
   progress.to hepat. necros. & somet.death, bld.dyscras., non-product.   GI disords., dry mouth, pancreatit., impot., ren.insuffic.& ac.ren.fail.,   angio-oed. occurs., activ.renin-angiotens.syst., mild to mod. ren./
   cough, ser. K elev., psych./CNS effs., headache, dizzin., vertigo, par-  jaund., hepatit., asthen., musc.cramps, cough, dyspn., bronchosp.,   hepat.impairm., haemodynamic.relev. left-ventricul. inflow/outflow
        +
   aesthes., vis. disturbs., tinnit., dysrhythm., ang. pect., MI, stroke, or-  rhinit., sinusit., skin rash incl.tox.epiderm.necrolys. /Stev.John.syndr   impedim., ensure stable circulat.condit., wasp/bee venom hyposen-
   thostat.eff., palpitat., dyspn., bronchosp., eosinophil.pneum., rhinit., GI   & erythema multiforme, psorias., sweat., photosens., vis.disturbs.,   sitisat. as sev.anaphylact.reacts.poss., diabet., monit.WBC & urine
   disords., dry mouth, pancreatit., skin reacts. incl.erythema multiforme,   tinnit., sympt. complex. incl.poss.antinucl.antibod.  prot.lev.with collagen vasc. dis.assoc.with imp.ren.funct.,concom.
   musc.cramps, ren. insuffic./fail., impot., asthen., sweat., hyperkalaem.  Special precautions: Cerebrovasc.dis., ischaem. heart dis., vol.&/  corticoster. & antimetabolit., surg., anaesthes., alcoh. incr.vasodilat.,
   Special precautions: No re-challenge aft. angioed. react., pass.  salt deplet., symptomat. hypotens., sev.autoimmune dis.esp.SLE/oth-  incr.diet.salt intake may attenuat. antihypertens.eff.
                                                                              -
                                                                        -
   through placenta, discont. ther./ switch to diff. class of meds.if pregn.  er collag. vasc.dis./scleroderma, ren.dysfunct., ac.MI, ac. MI where   Drug interactions: Kspar.diuret.& Ksupplem. incr. hyperkalaem.
   occurs, alter. meds.if pregn. contempl., vol. &/ salt deplet., sev. renin-  risk of furth.ser.haemodynam. deteriorat. exists, bonemarr.depress.,   risk, enhanc.hypoglycaem.eff.of antidiabet. agents poss., antihy-
   depend.hypertens., CHF, ischaem. heart/ CV dis., ren.impairm.(creatin.  diab.mellit., hyperkalaem., renovasc.dis., sngl./bilat.ren.artery stenos.,   pertens.& other subst. with BP low.potent.will potentiat.respons.,
   clear.&lt; 60 ml/ min.), discont. curr.diuret.bef.init.ther., renovasc. hyper-  ren.transplant, immunosuppress.ther., anaphylact. reacts.dur.hyme-  sympathomimet. may reduc.antihyptertens.eff., poss. incr.in hae-
   tens., ac.MI, expos.to high flux membr. dialys., no exper.in rec.ren.  noptera desensitisat. treatm./ expos.to high flux membr.dialys./low-  matologic.reacts.with allopurinol, immunosuppress., corticoster.,
   transpl., incr. angioed. incid.in black pts., angioed.hist.unrelat.to ACE   density lipoprot.apheres.with dextr.sulph.absorpt., incr. angioed.incid.  procainamide, cytostat. & other subst.that may change bld.pict.,
   inhib. ther., anaphylact.reacts.dur.hymenoptera desensitis. treatm./  in black pts., hyperkalaem.with K -spar. diuret., teratogenic. report.  reduc. Li excret., inhibit.of cytochrome P450 enzyme syst.may incr.
                                              +
                                                       +
   low dens.lipoprot.apheres.with dextr. sulph., sev.liv.funct. impairm.,   aft.1  trimest.of pregn., elderly, CF, monit.of concom.K -spar.diuret. /  felodipine plasma lev.while  induc. of cytochrome P450 enzyme syst.
                                  st
   discont.ther.if jaund./ mark.hepat.enzym. elevat.devel., WBC monit.   K  supplem./K  salt substit., surg./ anaesthes.  may decr. felodipine plasma lev., NSAID’s may attentuat. ramipril eff.&
                                 +
                                      +
   & pt.to report infect. signs esp.in collag. vasc. dis./concom.immuno-  Drug interactions: Hypotens.eff.incr.by other antihypertens. pro-  incr.risk of worsen.ren.funct.
   suppress.ther./ allopurinol/ procainamide, maj.surg./ dur. anaesthes.,   duc.meds./alcohol & diuret., antihypertens. eff.reduc.by NSAID’s   TRITACE, Sanofi-Aventis [P/S]
                                                          +
                                                   +
   uncontrol.diab.mellit., concom.diuret./ other meds.assoc.with incr.ser.  & indomethacin, poss.hyperkalaem.with K supplem. & K -spar.  Ramipril.
               +
   K , concom.K -spar. diurets./K  supplem./K  salt substit.not recomm.,   diuret., ser.Li incr.  Indications: Mild to mod.hypertens., card.fail. follow.MI., reduc.pro-
                    +
   +
        +
   dehydrat.pts., monit.with concom.K -spar. diuret. /Li lev., discont.  teinur.& glomerul.filtrat.rate decline in diabet.nephropathy & hyper-
                  +
   ther.immed.& appropr.treatm.if angioed./ ser.hypersens.reacts.oc-  SPEC PERINDOPRIL PLUS, Specpharm.  ten., to reduc. MI/stroke/CV death risk & need for revascularizat. pro-
   cur, mitral valve stenos., left ventr.outflow obstruct., bil. ren.artery   Perindopril tertbutylamine salt (2)4 mg, indapamide (0,625)1,25 mg  ced.in pts.with incr.CV risk, reduc. MI/stroke/CV death risk in diabetics
   stenos., stenos.of artery to solit.kidn., pts.≥ 70 yrs., hypovolaem.,   Indications: Essent.hypertens.where pt. stabil. on indiv.compon.  (S3) TABS. 31/7.1.3/0666, 0667.
   hyponatraem., pre-exist. hypotens., unstab. CF, concom.high-dos.   at same dos.range.  841587-019: 2,5 mg, 30, R259,42
   vasodilat. ther., diet.salt restrict., dialys., diarrh.& vomit.  (S3) TABS, 41/7.1.3/0630, 0631  841595-003: 5 mg, 30, R411,54
   Drug interactions: Poss.Li-toxic., reduc. antihypertens. eff.with   713762-001: 2/0,625 mg, 30, R102,51  (S3) CAPS. W/7.1.3/235.
   NSAIDs, poss.incr. hypoglycaem. risk with insul./oral antidiab.  713763-001: 4/1,25 mg, 30, R104,95  782602-002: 10 mg, 30, R443,19
   agents, incr. hypotens.eff.with cert.anaesthet./TCA’s/ anti-psychot./  Dosage: Take once dly.in morn.bef.meal  Dosage: Hypertens: 2,5 mg dly in pts.not on diuret. Incr.to 5 mg and
   nitroglycer.& other nitrat./other vasodilat., reduc.antihypertens.eff.  Contraindications: Sulphon.sens., angioed. hist.link.to prev.ACE   max.10 mg dly at 1-2 wk. interv.depend.on respon.
   with sympathomimets., incr.hypokalaem.eff.with other meds. caus.  inhibit./angiotens.recept. block.ther., heredit./idiopath.angioed.,   Post MI: Init. 3-10 days aft.ac.MI if heart fail manifests &
                         +
   hyperkalaem. e.g.ciclospor., poss. hyperkalaem. with K supplem./K   +  aort. stenos., hypertroph.obstruct.cardiomyopathy, uncompens.   pt.haemodynamic stable at 2,5 mg 2xdly x2 days incr.to 5 mg 2xdly
   salt substit./K -spar. diuret.  card.fail., sev.ren.funct.impairm. (creatinine clear.&lt;30 ml/min.), bil.  if well tol. If init. dos.of 2,5 mg not tol.init.with 1,25 mg 2xdly incr.
         +
                                ren.artery stenos., sngl.ren.artery stenos.in pts.with sngl. kidn.,
   SINOPREN, Ranbaxy [P/S]      concom.Li/K spar.diuret./supplem., porphyr., Addisons dis., hypoka-  to 2,5 mg 2xdly.
                                      +
   Lisinopril                   laem., hepat. cirrhos., sev.liv.funct.impairm., pregn., lactat., safety   Non-diabet.& diabet.nephropathy: Init.1,25 mg dly. Accord.
   Indications: Mild to mod.hypertens., adjunct in congest.HF., aft.ac.MI  &effic.in childr.not est.  to respons.doubl.dos.at 2-3 wk.interv. Max. 10 mg dly. Consid.dis-
   (S3) TABS. 35/7.1.3/0209, 0210, 0211  Side effects: Bld.dyscras., orthostat.effs., hypotens., MI, cerebro-  cont.diuret for 2-3 days bef. init.treatm.or at least reduc.diuret.dos.
   700691-001: 5 mg, 30, R28,65  vasc.accid., palpitat., tachycard., chest pain, CNS effs., asthen., hy-  MI/stroke/CV death risk reduct.: Init: 2,5 mg once dly. Incr.grad.
   700692-001: 10 mg, 30, R28,65  pokalaem., hyperkalaem., hyponatraem., rais. plasma Ca lev., pre-  depend.on tol.in which case dos. should be doubl.aft.one wk & doubl.
   700694-001: 20 mg, 30, R28,65  cipitat.second.gout, GI disturbs., pancreatit., impot., ren.dysfunct.,   again aft. 3 wks. to usual maint.dos.of 10 mg once dly.
   Dosage: Admin.as sngl.dly dos.  ac ren. fail., jaund., hepatit., musc.cramps, cough, bronchosp., rhinit.,   Contraindications: Angioneurot.oed., childr., hepat.impairm.,
   Mild to mod.hypertens: Init.10 mg once dly. Usual effect.maint.dos   sinusit., prurit., urticar., diaphores., alopec., psorias., sev.skin disords.   pregn.& lactat., dialysis.
   20 mg as sngl.dly.dos. Adjust accord.to respons. If therapeut.respons.  incl.tox.epiderm.necrolys./Stev.-John.syndr.& erythema multiforme,   Side effects: Naus., dizz., headache, cough, hypotens., hyper-
   not achiev.in a period of 2-4 wks.with cert.dos.lev. dos. can be incr.  photosens., hypersens. reacts., vis.disturbs., sympt.complex report.  kalaem., angioneurot.oed., allerg.reacts., GI-disturbs.
   further. Max. 40 mg/day. Pts.on diuret: Init: 5 mg/day.  incl. fev./vasculit./myalg./arthrit./arthralg.& posit. antinucl.antibod.  Special precautions: Imp.ren.funct., CCF, ren. vasc. dis., surg.&
   Congest.heart fail: Pts.not adeq.contr.by digital./ diuret.add   Special precautions: Cerebr.vasc.dis./ ischaem. heart dis., salt/vol.  anaesthes., monit.WBC & prot. urine lev.with collagen vasc.dis.
                                                              where assoc. with imp. ren.funct.& concom.corticoster.& antime-
   init.2,5 mg dly. Adjust accord.to respons. incr.grad.at 4 wk.interv.to   deplet., autoimmune dis.esp.SLE, other collag.vasc.dis., scleroderma,
   maint.dos.of 5-20 mg once dly.   immunosuppress.pts., ac.MI, ac.MI pts.at risk of furth.ser.haemody-  tabol., if poss.discont.diuret.2-3 days bef. commenc.ther.otherwise
                                                              init.dos.should be 1,25 mg
   Ac.MI: Start treatm.within 24 hrs.of sympt.onset. Init.5 mg follow.  nam.deteriorat.aft.vasodilat.treatm., bone marr.depress., diab.mellit.,
   by 5 mg aft.24 hrs., 10 mg aft.48 hrs. & then 10 mg once dly there-  hyper-/hypokalaem., concom.K supplem./K -spar. diuret. / K  salt sub-  Drug interactions: Diuret.& antihypertens. potent. respons., anti-
                                                  +
                                                        +
                                             +
                                                              hypertens.eff.decr.by NSAID’s, K-spar.diuret.incr.hyperkalaem.risk,
   aft. Cont.for 6 wks.         stit./meds.assoc.with K lev. changes, monit.K lev.reg., renovasc.dis.,   attenuate K-loss with thiazides, Li-conc.incr.
                                          +
                                                   +
   Renovasc.hypertens: Low.dos.to 2,5 or 5 mg. Monit.pt.  ren. artery stenos., ren.funct.impairm., anaphylact. reacts.dur. hyme-
   Contra-indications: Pregn., safety in lactat. not est., angioneurot.  noptera desensitisat.treatm./ expos.to high flux membr.dialys./low-  TRITACE PLUS, Sanofi-Aventis
   oed.hist., heredit./idiopath. angioed., aort.stenos., hypertroph.cardio-  density lipoprot.apheres.with dextr.sulph.absorpt., angioed., high.an-  Ramipril 10 mg, hydrochlorothiazide 12,5 mg
                                                          nd
   myopathy, safety & effectiven.in childr.not est.  gioed.incid.in black pts., foet. abnormalit.report.aft.admin.in.2  & 3   rd  Indications: Essent.hypertens.where pt.stabil.on indiv.compon.
   Side effects: CNS effs., fatig., cough, GI disturbs., hypotens., skin   trimest., sev.hepat.impairm., elderly, atheroscleros., hypotens., incr.  at propos.dos.
   reacts. incl.epiderm.necrolys./Stev-John.syndr./erythema multiforme,   tenden.to gout., electrol.disturbs., strict Na-free diets., ensure adeq.  (S3) TABS, 43/7.1/1130
   asthen., hypersens. reacts., angioneurot.oed., CV effs., cerebrovasc.  hydrat., sev. card. insuffic./insul.depend.diab.start ther.with only 1   718093-001: 10/12,5 mg, 28, R140,38
   accid., pancreatit., resp.effs., sweat., alopec., prurit., psorias., uraem.,   constit., maj.surg./anaesthes., posit.react. for athletes in drug tests.  Dosage: Do not crush/ chew tabs. Indiv. Dos. should be determ.by ti-
   oligur., anuria, ac.ren.fail., impot., sympt.complex incl.arthralg., my-  Drug interactions: Poss.incr.Li lev., hypoglycaem. eff.of insul.& hy-  trat.of indiv.compon. When success.titrat. Tritace Plus may be substit.
   alg., posit.anti-nuclear antibody, bld.dyscras., rash, photosens.& other   poglycaem.agents incr., baclofen potent.antihypertens.eff., ac.ren. in-  if titrat. & dos.sched. achiev.by fix.combinat. Usual: 2,5 mg ramipril &
   dermatologic.manifestat., hyperkalaem.,  suffic.in dehydrat.pts.& concom.NSAIDS & high dos.salicylat., TCA’s/  12,5 hydrochlorothiaz.(corresp.to 1 tab. Tritace Plus 2,5 mg/12,5 mg)
   Special precautions: Salt & vol.deplet.pts., where poss.discont.  neurolept./anaesth./diuret. / alcoh.& antihyperten.agents incr.antihy-  dly. Admin.as a sngl dos. in morn. Titrat.accord.to sev.of hypertens.&
   diuret.2-3 day bef.start. treatm., ren.impairm., renovascul.hypertens.,   pertens. eff., corticoster.& tetracosactide reduc. antihypertens. eff.,   other assoc. risk fact. Max.dly dos: 10 mg ramipril & 50 mg hydro-
                                 +
   CHF, concom.diuret., symptomat.hypotens., ischaem. heart/cerebro-  K supplem./-spar.diuret.incr. K  lev./K  low.meds., allopurin./cytostat/   chlorothiaz. Take miss.dos. as soon as poss.provid.not almost time
                                               +
                                             +
   vas.dis., do not init.in ac.MI pts.at risk of further ser.haemodynam.  immunosuppress. /system.corticoster & procainamide incr.leucopen.  for next dos. Do not double dos.
   deteriorat.aft. vasodilat.treatm., caref.monit.of BP follow.infarct. &   risk, non anti-arrhythm. drugs which prolong QT interv./cause torsades   Contraindications: Safety & effic.in childr.not est., pre-exist.liv.ab-
   poss.dos.adjustm., bil.ren.artery stenos/arter. stenos.to solit.kidn.,   de pointes, anti-arrhythm.drugs prod. torsades de pointes as low K+   norm., hypertroph. obstruct. cardiomyopathy, bi-/ unilat.ren.art.stenos.
   consid.withdr.if ren.dysfunct. develops.dur.treatm., haemodialys.  lev.are a risk fact. for arrythm, NSAID’s & sympathomim.reduc. an-  in pres. of sngl.kidn., aortic.stenos., porphyr., mod.to sev.ren. funct.
   proced.with high flux membr., hist.of angioed.unrelat.to ACE-inhibit.  tihypertens. eff., card.glycosides tox.effs.fav. by low.K lev., lact.aci-  impairm., concom.K-spar.diurets., Li-ther., hist.of angioed.with ACE-
                                                       +
   ther., anaphylact.reacts.dur.hymenoptera desensitisat.treatm., surg./  dos.with metformin, iodinat. contrast med.incr.risk of ac.ren.insuffic.  inhibit./ ARB’s, heredit./idiopath angioed., pregn.& lactat., Addison’s
   anaesth., diab.mellit., concom.K-spar.diuret./supplem.  in pres. of dehydrat., reduc.urin.Ca eliminat.poss. incr. Ca lev. with Ca   dis., sev.ren.funct.impairm./ anur., sulphonam.sens.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page142.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page138.html">138</a>&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>
             </td>
             <td width="35%"><a href="page144.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page144.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
